PTEN (also known as Posphatidylinositol-3, 4, 5-trisphosphate 3-phosphatase, and dual-specificity protein phosphatase) is a member of the PI3K/PTEN/Akt pathway and a tumor suppressor. Defects of the antibody have been implicated in human cancers, including prostate, breast, thyroid, endometrium, skin, neck, brain, and head. Up to 60 percent of the advanced prostate cancers now show abnormal […]